(3) Given the many different PTMs and regulatory sites of PPARγ, along with their apparent involvement in EC dysfunction, increasing attention will continue to be directed towards PPARγ regulation in other metabolic and cardiovascular diseases. This evidence concerns the gene PPARG and cardiovascular disorder.